Results 61 to 70 of about 313,244 (194)

Recombinant anti-monkey CD3 immunotoxin depletes peripheral lymph node T lymphocytes more effectively than rabbit anti-thymocyte globulin in naive baboons

open access: yes, 2013
T cell depletion is an important procedure for both experimental and therapeutic immune modulation. Rabbit anti-thymocyte globulin (ATG), which is a commonly used T cell depletion antibody in clinical organ and cell transplantation protocols, is ...

core   +1 more source

Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer

open access: yesMedComm, Volume 7, Issue 10, October 2026.
Mesothelin overexpression activate important pathways like nuclear factor k‐light‐chain‐enhancer of activated B cells (NF‐κB) and interleukin‐6 (IL‐6). This in turn causes numerous cancers, such as pancreatic and ovarian cancers. MSLN‐targeting immunotherapies, like monoclonal antibodies, have shown efficacy.
Manoj Kumar Gupta   +2 more
wiley   +1 more source

Integrated bioprocessing and genetic strategies to enhance soluble expression of anti-HER2 immunotoxin in E. Coli

open access: yesAMB Express
Immunotoxins are widely applied for cancer therapy. However, bacterial expression of immunotoxins usually leads to the formation of insoluble and non-functional recombinant proteins. This study was aimed to improve soluble expression of a novel anti-HER2
Sheida Mani   +3 more
doaj   +1 more source

Directing ricin-based immunotoxins with targeting affibodies and KDEL signal peptide to cancer cells effectively induces apoptosis and tumor suppression

open access: yesJournal of Nanobiotechnology, 2022
The plant toxin ricin, especially its cytotoxic A chain (RTA), can be genetically engineered with targeting ligands to develop specific anti-cancer recombinant immunotoxins (RITs).
Seong Guk Park   +5 more
doaj   +1 more source

Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII

open access: yesMolecular Therapy: Methods & Clinical Development, 2021
Hematopoietic stem and progenitor cell (HSPC) lentiviral gene therapy is a promising strategy toward a lifelong cure for hemophilia A (HA). The primary risks associated with this approach center on the requirement for pre-transplantation conditioning ...
Athena L. Russell   +9 more
doaj   +1 more source

Genome Manipulation in Microalgae: A Systematic Map on Improved Traits, Strains, and Their Commercial Applications

open access: yesReviews in Aquaculture, Volume 18, Issue 4, September 2026.
ABSTRACT Microalgae are promising platforms for producing diverse biocompounds relevant to multiple commercial sectors, and the use of genomic technologies in microalgae is rapidly expanding. To examine the research trends, we conducted a bibliographic analysis (systematic map) of this rapidly developing field. Our study presents a descriptive overview
Irene Gallego   +2 more
wiley   +1 more source

Actinomycin Derivatives: Structural Diversification and Biological Activities

open access: yesChemMedChem, Volume 21, Issue 15, 14 August 2026.
Actinomycins are chromopeptide antibiotics exhibiting remarkable structural diversity and broad bioactivity. This review traces their development from naturally occurring D‐, X‐, A‐, G‐, Y‐, and Z‐type analogs to precursor‐directed, synthetic, and semisynthetic derivatives.
Özge Can, Erdal Bedir
wiley   +1 more source

A cleavable adapter to reduce nonspecific cytotoxicity of recombinant immunotoxins [PDF]

open access: yesInternational Journal of Cancer, 2002
AbstractOne of the problems associated with the administration of immunotoxins is hypersensitivity reaction such as vascular leak syndrome. This may be prevented by decreasing the plasma half‐life. To improve immunotoxins with respect to reduced side effects, we have previously described the development of a cleavable adapter.
Iring, Heisler   +4 more
openaire   +2 more sources

De Novo Synthesis in Cancer Immunotherapy: Applications and Prospects

open access: yesMedComm, Volume 7, Issue 7, July 2026.
De novo protein design creates novel structures for cancer immunotherapy, integrating rational design principles like modularity and specificity. Leveraging computational tools, it optimizes cytokine engineering, adoptive cellular therapy, and checkpoint regulation to enhance antitumor immunity.
Yang Jin, Yanfeng Wu, Jianhua Luo
wiley   +1 more source

Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies [PDF]

open access: yesCurrent Pharmaceutical Design, 2009
Recombinant immunotoxins are proteins composed of fragments of monoclonal antibodies fused to truncated protein toxins. No agents of this class are approved yet for medical use, although a related molecule, denileukin diftitox, composed of interleukin-2 fused to truncated diphtheria toxin, is approved for relapsed/refractory cutaneous T-cell lymphoma ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy